Autopsy report · NCT06038760

Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of funding”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 1 year 9 months before it stopped.
12 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Ourotech, Inc.
Sponsor type: Industry
Conditions: Brain Tumor; Glioma, Malignant; Ependymoma; Oligodendroglioma; Glioblastoma
Interventions: Resection
Participants: 12
Sites: 1
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.